IRIDEX Corporation (NASDAQ: IRIX) is a global ophthalmic medical technology company specializing in innovative laser-based systems for the treatment of glaucoma and retinal diseases. The company’s portfolio includes laser platforms, delivery devices, and treatment technologies designed to help eye care professionals manage vision-threatening conditions while improving patient outcomes.

Topics discussed include IRIDEX’s product portfolio, commercialization efforts, market opportunities, growth strategy, and long-term outlook within the global ophthalmology market.

This company webcast was recorded during the Lytham Partners Spring 2026 Investor Conference.